TRINA GREENWALD: Open Payments
NPI 1548298409 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,822 in 193 payments from 18 companies in 2025. Trend: 2023 $21,036 · 2024 $33,788 · 2025 $44,822
Speaker / faculty: $21,290Travel & lodging: $9,899Honoraria: $7,963Food & beverage: $3,190Consulting: $2,480
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 49 | $30,640 |
| Axsome Therapeutics, Inc. | 23 | $9,414 |
| ABBVIE INC. | 22 | $3,302 |
| Lundbeck LLC | 20 | $250 |
| Neurocrine BioSciences, Inc. | 19 | $232 |
| Otsuka America Pharmaceutical, Inc. | 15 | $213 |
| E.R. Squibb & Sons, L.L.C. | 15 | $167 |
| Corium, LLC | 8 | $158 |
| Tris Pharma Inc | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
Products named: CAPLYTA, Auvelity, VRAYLAR, REXULTI, INGREZZA, Azstarys, COBENFY, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
